Overview A Long-Term Safety Study of ALKS 5461 Status: Completed Trial end date: 2017-11-20 Target enrollment: Participant gender: Summary This is a 52-week open-label study to evaluate the safety and tolerability of ALKS 5461. Phase: Phase 3 Details Lead Sponsor: Alkermes, Inc.